To amend the Federal Food, Drug, and Cosmetic Act with respect to the pharmaceutical distribution supply chain, and for other purposes.
The bill’s titles are written by its sponsor.
Sponsor and status
113th Congress (2013–2015)
This bill was introduced in a previous session of Congress and was passed by the House on June 3, 2013 but was never passed by the Senate. Provisions of this bill were incorporated into other bills.
Although this bill was not enacted, its provisions could have become law by being included in another bill. It is common for legislative text to be introduced concurrently in multiple bills (called companion bills), re-introduced in subsequent sessions of Congress in new bills, or added to larger bills (sometimes called omnibus bills).
Provisions of this bill also appear in:
20 Cosponsors (15 Republicans, 5 Democrats)
Position statements
What legislators are saying
“Latta Comments on President Signing Legislation to Combat Counterfeit Pharmaceuticals”
—
Rep. Robert Latta [R-OH5]
(Sponsor)
on Nov 27, 2013
“Upton Hails House Passage of Critical Health Bills to Support Animal Drug Programs, Secure Prescription Drug Supply Chain”
—
Rep. Fred Upton [R-MI6, 1993-2022]
(Co-sponsor)
on Jun 3, 2013
“Collins, King Pledge to Defend Maine Patient Safety, Papermaking Interests”
—
Sen. Angus King [I-ME]
on Jun 4, 2013
History
|
May 9, 2013
|
|
Introduced
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber. |
|
May 14, 2013
|
|
Considered by House Committee on Energy and Commerce
A committee held a hearing or business meeting about the bill.
|
|
Jun 3, 2013
|
|
Passed House (Senate next)
The bill was passed in a vote in the House. It goes to the Senate next. The vote was by voice vote so no record of individual votes was made. |
|
Jun 3, 2013
|
|
Text Published
Updated bill text was published as of Reported by House Committee. |
|
Sep 28, 2013
|
|
Related Bill —
Passed House (Senate next)
This activity took place on a related bill, H.R. 3204 (113th), possibly in lieu of similar activity on H.R. 1919 (113th). |
|
Nov 18, 2013
|
|
Related Bill —
Passed Senate
This activity took place on a related bill, H.R. 3204 (113th), possibly in lieu of similar activity on H.R. 1919 (113th). |
|
Nov 27, 2013
|
|
Related Bill —
Enacted — Signed by the President
This activity took place on a related bill, H.R. 3204 (113th), possibly in lieu of similar activity on H.R. 1919 (113th). |
H.R. 1919 (113th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
Bills numbers restart every two years. That means there are other bills with the number H.R. 1919. This is the one from the 113th Congress.
This bill was introduced in the 113th Congress, which met from Jan 3, 2013 to Jan 2, 2015. Legislation not passed by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
“H.R. 1919 — 113th Congress: Safeguarding America’s Pharmaceuticals Act of 2013.” www.GovTrack.us. 2013. March 25, 2023 <https://www.govtrack.us/congress/bills/113/hr1919>
- show another citation format:
- APA
- Blue Book
- Wikipedia Template
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.
